Tilray Brands Inc
XETRA:2HQ
Tilray Brands Inc
XETRA:2HQ
Price:
6.274
EUR
1.41%
Market Cap:
€5.2B
Relative Value
The Relative Value of one
2HQ
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 6.274 EUR,
Tilray Brands Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
2HQ Relative Value
HIDDEN
Multiples Across Competitors
2HQ Competitors Multiples
Tilray Brands Inc Competitors
Tilray Brands Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Tilray Brands Inc
XETRA:2HQ
|
875.1m EUR | 1 | -0.4 | 47.7 | -10.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD | 15.3 | 48.2 | 32.5 | 34.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
584.7B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.9B CHF | 4.8 | 31.1 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.4B GBP | 5.6 | 31.9 | 17.6 | 24.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
246.5B CHF | 5.6 | 22.7 | 14 | 17.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.7B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.8B USD | 2.5 | 20 | 7.4 | 9.9 | |
| UK |
|
GSK plc
XETRA:GS71
|
104B EUR | 2.8 | 15.8 | 8 | 11.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
